MMRF CureCloud Research Initiative

Stopped early

Conditions studied: Multiple Myeloma

In brief

The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing collection of their electronic medical records information.

Key facts

Study ID

NCT03657251

Run by

Multiple Myeloma Research Foundation

People needed

1105

Starts

2020-07-14

Expected to finish

2023-12-31

Last updated by the study team

2024-01-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with active Multiple Myeloma
• Patients have signed an online consent form

You may not qualify if…

• Patients who live outside the United States
• Patients with a diagnosis other than Multiple Myeloma or a known or suspected precursor to Multiple Myeloma

Where it is running

• Multiple Myeloma Research Foundation — Norwalk, Connecticut, United States
• Washington University Medical Campus — St Louis, Missouri, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• University of Texas Southwestern Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.